Mark Litwin

Mark Litwin serves as a Distinguished Professor of Urology at the David Geffen School of Medicine, University of California, Los Angeles. His academic appointment resides within the Department of Urology at UCLA Health, where he contributes to clinical and research initiatives in urological oncology.

His research focuses on urological malignancies, particularly prostate and bladder cancer. Key areas include tumor biology, surgical interventions, and translational research aimed at improving diagnostic and therapeutic outcomes for urologic cancer patients. His work bridges clinical practice with laboratory investigations to advance precision oncology approaches.

While specific awards or educational background are not detailed in the provided text, his distinguished professorship signifies recognition of significant contributions to urological science and patient care. His role encompasses clinical responsibilities, research leadership, and academic mentorship within UCLA's urology division.